“…We must keep in mind that thrombosis as a manifestation of HIV has already been reported characterizing a hypercoagulable state and that thromboembolic events may become more frequent in this group [2,9,10]. Thrombotic emergency has a raised risk of mortality and anticoagulation alone may not solve the problem, pharmacomechanical thrombolysis with recombinant tissue plasminogen activator and endovascular tools for rapid clot removal utilizing percutaneous mechanical device as Aspirex TM S-Straub Medical Aspirex® or Rotarex ® must be used for complete thrombus removal [10]. To treat vessels occlusion a successful percutaneous pharmacomechanical thrombectomy have been reported in patients infected with HIV [11].…”